[HTML][HTML] Effective and safe proton pump inhibitor therapy in acid-related diseases–a position paper addressing benefits and potential harms of acid suppression

C Scarpignato, L Gatta, A Zullo, C Blandizzi… - BMC medicine, 2016 - Springer
Background The introduction of proton pump inhibitors (PPIs) into clinical practice has
revolutionized the management of acid-related diseases. Studies in primary care and …

Association of antidepressant use with adverse health outcomes: a systematic umbrella review

E Dragioti, M Solmi, A Favaro, P Fusar-Poli… - JAMA …, 2019 - jamanetwork.com
Importance Antidepressant use is increasing worldwide. Yet, contrasting evidence on the
safety of antidepressants is available from meta-analyses, and the credibility of these …

[HTML][HTML] Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults

ML Piel‐Julian, M Mahévas, J Germain… - Journal of Thrombosis …, 2018 - Elsevier
Essentials• Risk factors of bleeding in adult immune thrombocytopenia are not known.• This
multicenter study assessed risk factors of bleeding at immune thrombocytopenia onset.• …

[HTML][HTML] Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19

M Mahdi, L Hermán, JM Réthelyi, BL Bálint - International Journal of …, 2022 - mdpi.com
Mapping non-canonical cellular pathways affected by approved medications can accelerate
drug repurposing efforts, which are crucial in situations with a global impact such as the …

Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and …

S Nochaiwong, C Ruengorn, R Awiphan… - Annals of …, 2022 - Taylor & Francis
Background Serotonin reuptake inhibitor (SRI) antidepressants are implicated in increasing
the risk of bleeding among users; however, the comparative increase in bleeding risk with …

Selective serotonin reuptake inhibitors

RM Chow, M Issa - Pain Medicine: An Essential Review, 2017 - Springer
Selective Serotonin Reuptake Inhibitors Page 1 167 © Springer International Publishing
Switzerland 2017 RJ Yong et al. (eds.), Pain Medicine, DOI 10.1007/978-3-319-43133-8_43 …

Selective serotonin reuptake inhibitors (SSRIs) in pregnancy: an updated review on risks to mother, fetus, and child

LG Lebin, AM Novick - Current psychiatry reports, 2022 - Springer
Abstract Purpose of Review To provide an updated summary and appraisal of work from
2019 to 2022 examining risks of selective serotonin reuptake inhibitor (SSRI) use in …

[PDF][PDF] Fluoxetine use is associated with improved survival of patients with COVID-19 pneumonia: A retrospective case-control study.

ZK Németh, A Szûcs, J Vitrai, D Juhász… - Clinical Neuroscience …, 2021 - real-j.mtak.hu
Background and purpose–We aimed to investigate the association between fluoxetine use
and the survival of hospitalised coronavirus disease (COVID-19) pneumonia patients …

Concomitant Use of Selective Serotonin Reuptake Inhibitors With Oral Anticoagulants and Risk of Major Bleeding

AA Rahman, RW Platt, S Beradid, JF Boivin… - JAMA Network …, 2024 - jamanetwork.com
Importance Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed
antidepressants associated with a small increased risk of major bleeding. However, the risk …

[HTML][HTML] Harder, better, faster, stronger? Retrospective chart review of adverse events of interactions between adaptogens and antidepressant drugs

M Siwek, J Woroń, A Wrzosek, J Gupało… - Frontiers in …, 2023 - frontiersin.org
Aim: We aimed to systematically evaluate the prevalence and clinical characteristics of
adverse events associated with the adaptogens and antidepressant drug interactions in a …